Abstract
Background
Presentation of antibiotic utilization data by reliable and comparable analyses constitutes an important way of ensuring rational use of antibiotics. This study aimed to evaluate antibiotic consumption (AC) of Turkey by each city/region and to investigate any association of such consumption with socio-economic factors.
Method
For 81 provinces and 12 regions in Turkey, AC data from IMS (Intercontinental Medical Statistics) in 2011 was analyzed in accordance with “ATC/DDD, DID” (Anatomical Therapeutic Chemical/Defined Daily Doses, DID = DDD/1000 inhabitants/day) methodology supported by World Health Organization. Association between provincial AC rates and socio-economic development index (SEDI)-2011 and between regional AC rates and some health indicators were analyzed.
Results
While provincial AC data of Turkey was detected to vary between 17.2 and 55.2 DID (Hakkari and Usak, respectively), regional AC ranged from 28.4 to 48.9 DID (Middle Eastern Anatolia and Western Anatolia, respectively). Mostly consumed antibiotic group among all regions were beta-lactamase inhibitor/penicillin combinations (range: 9.9–17.6 DID). SEDI and AC of each city showed positive correlation (rho = 0.683, p < 0.001). While regional AC was positively associated with percentage of 14-year-old population (p = 0.002) and pharmacist density (p < 0.001), it was negatively associated with physician density (p = 0.038).
Conclusion
It is remarkable that Turkey, at both provincial and regional levels, exhibits important variations in AC, which is proportional to socio-economic status. Besides, the consumption is found to be closely associated with recognized critical factors of access to healthcare. These findings are expected to provide important insights to the activities promoting rational use of antibiotics.
Similar content being viewed by others
References
Holloway KA, van Dijk L, World Health Organization (2011) The world medicines situation, third edition. WHOb/EMP/MIE/2011.2.2. World Health Organization, Geneva
ECDC/EMEA. Technical Report. The bacterial challenge: time to react. Sept 2009. http://www.ecdc.europa.eu/en/publications/Publications/0909TER_The_Bacterial_Challenge_Time_to_React.pdf (accessed at December 27, 2016)
US Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States, 2013. April 2013. http://www.cdc.gov/drugresistance/threat-report-2013/pdf/ar-threats-2013-508.pdf (accessed at December 27, 2016)
Hosoglu S, Karabay O (2013) Healthcare expenditures and increasing antimicrobial consumption in Turkey. J Chemother 25(1):63
Global Action Plan on Antimicrobial Resistance. World Health Organization. 2015, ISBN 978 92 4 150976 3
Masiero G, Filippini M, Ferech M, Goossens H (2010) Socioeconomic determinants of outpatient antibiotic use in Europe. Int J Public Health 55(5):469–478
Bronzwaer SL, Cars O, Büchholz U, Molstad S, Goettsch W, Veldhuijzen IK, Kool JL, Sprenger MJ, Degener JE, European Antimicrobial Resistance Surveillance System (2002) A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerg Infect Dis 3:278–282
Aabenhus R, Siersma V, Hansen MP, Bjerrum L (2016) Antibiotic prescribing in Danish general practice 2004–13. J Antimicrob Chemother. doi:10.1093/jac/dkw117
Versporten A, Bolokhovets G, Ghazaryan L, Abilova V, Pyshnik G, Spasojevic T, Korinteli I, Raka L, Kambaralieva B, Cizmovic L, Carp A, Radonjic V, Maqsudova N, Celik HD, Payerl-Pal M, Pedersen HB, Sautenkova N, Goossens H, WHO/Europe-ESAC Project Group (2014) Antibiotic use in eastern Europe: a cross-national database study in coordination with the WHO regional Office for Europe. Lancet Infect Dis 14(5):381–387
Elseviers MM, Ferech M, Vander Stichele RH, Goossens H (2007) Antibiotic use in ambulatory care in Europe (ESAC data 1997–2002): trends, regional differences and seasonal fluctuations. Pharmacoepidemiol Drug Saf 16(1):115–123
Matuz M, Benko R, Doro P, Hajdu E, Nagy G, Nagy E, Monnet DL, Soos G (2006) Regional variations in community consumption of antibiotics in Hungary, 1996–2003. Br J Clin Pharmacol 61:96–100
T.C. Sağlık Bakanlığı Refik Saydam Hıfzıssıhha Merkezi Başkanlığı, Hıfzıssıhha Mektebi Müdürlüğü. Hekimlerin Akılcı İlaç Kullanımına Bakışı [Physicians’ Perspective of Rational Drug Use]. Akdag R (Ed.), Araştırma serisi: 10, Ankara 2011. Sağlık Bakanlığı Yayın No: 857. ISBN: 978–975–590-396-5
T.C. Sağlık Bakanlığı Refik Saydam Hıfzıssıhha Merkezi Başkanlığı, Hıfzıssıhha Mektebi Müdürlüğü. Birinci Basamakta Akılcı Reçete Yazımı [Writing Rational Prescriptions in Primary Health Care Centers]. Akdag R (Ed.), Araştırma serisi: 7, Ankara 2011. Sağlık Bakanlığı Yayın No: 854. ISBN: 978–975–590-400-9
Mollahaliloglu S, Alkan A, Donertas B, Ozgulcu S, Akici A (2011) Assessment of the prescriptions written in different provinces of Turkey in terms of drug utilization principles. Marmara Med J 24:162–173
T.C. Sağlık Bakanlığı Refik Saydam Hıfzıssıhha Merkezi Başkanlığı, Hıfzıssıhha Mektebi Müdürlüğü. Toplumun Akılcı İlaç Kullanımına Bakışı [Community Perspective of Rational Drug Use]. Akdag R (Ed.), Araştırma serisi: 9, Ankara 2011. Sağlık Bakanlığı Yayın No: 856. ISBN: 978–975–590-394-1
Ministry of Health (Turkey) (2012) Turkey health statistics yearbook 2011. Ministry of Health (Turkey), Ankara, Turkey
World Bank national accounts data, and OECD National Accounts data files. GDP per capita http://data.worldbank.org/indicator/NY.GDP.PCAP.CD?end=2011&locations=TR-1W&start=2011&view=bar (accessed at December 27, 2016)
Quintiles IMS Turkey web site. Available at http://www.imshealth.com/tr_TR (accessed at December 27, 2016)
WHO Collaborating Centre for Drug Statistics Methodology, Guidelines for ATC classification and DDD assignment 2015. Oslo, 2015
Ulusal Antibakteriyel İlaç Sürveyansı – 2011, National Antibacterial Drug Surveillance – 2011 Turkish Ministry of Health Publication No: 995, Ankara, 2015
T.C. Kalkınma Bakanlığı. İllerin ve Bölgelerin Sosyo-Ekonomik Gelişmişlik Sıralaması Araştırması (SEGE-2011) [Ministry of Development (Turkey), Survey of Socio-Economic Development Ranking of Provinces and Regions], Ankara 2013
European Centre for Disease Prevention and Control (2014) Surveillance of antimicrobial consumption in Europe 2012. ECDC, Stockholm
Goossens H, Ferech M, Vander Stichele R, Elseviers M, ESAC Project Group (2005) Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 365:579–587
SWEDRES (2006) A report on Swedish antibiotic utilisation and antibiotics in human medicine (2006) The Swedish Strategic Programme against Antibiotic Resistance and the Swedish Institute for Infectious Disease Control, ISSN 1400–3473
Kern W, Nink K, Steib-Bauert M, Schröder H (2006) Regional variation in outpatient antibiotic prescribing in Germany. Infection 34(5):269–273
Boccia D, Alegiani SS, Pantosti A, Moro ML, Traversa G (2004) The geographic relationship between the use of antimicrobial drugs and the pattern of resistance for Streptococcus pneumoniae in Italy. Eur J Clin Pharmacol 60(2):115–119
Patz JA, Githeko AK, McCarty JP, Hussein S, Confalonieri U (2008) Climate change and infectious diseases. Infect Dis 9(6):103–132
Sensoy, S. (2004) The mountains influence on Turkey climate. In: Balwois Conference on Water Observation and Information System for Decision Support
Božić B, Bajčetić M (2016) Seasonal variations in antibiotic consumption in paediatric primary care settings in Serbia. Arch Dis Child 101:e1. doi:10.1136/archdischild-2015-310148.57
Suda KJ, Hicks LA, Roberts RM, Hunkler RJ, Taylor TH (2014) Trends and seasonal variation in outpatient antibiotic prescription rates in the United States, 2006 to 2010. Antimicrob Agents Chemother 58(5):2763–2766
Kemper KJ, APA Standing Committee on Public Policy and Advocacy (2002) APA policy on clinical and environmental factors contributing to antibiotic resistant bacteria. Ambul Pediatr 2(3):230–233
Akici A, Kalaca S, Ugurlu MU, Oktay S (2004) Prescribing habits of general practitioners in the treatment of childhood respiratory-tract infections. Eur J Clin Pharmacol 60(3):211–216
Bozic B, Bajcetic M (2015) Use of antibiotics in paediatric primary care settings in Serbia. Arch Dis Child 100(10):966–969
Turkish Statistics Institution. Median Age by provinces and sex. Available at: http://www.turkstat.gov.tr/PreIstatistikTablo.do?istab_id=2306. (accessed at December 27, 2016)
Augustin J, Mangiapane S, Kern WV (2015) A regional analysis of outpatient antibiotic prescribing in Germany in 2010. Eur J Pub Health 25(3):397–399
World Health Organization (2014) The role of pharmacist in encouraging prudent use of antibiotics and averting antimicrobial resistance: a review of policy and experience in Europe. WHO Regional Office for Europe, Copenhagen
Llor C, Cots JM (2009) The sale of antibiotics without prescription in pharmacies in Catalonia, Spain. Clin Infect Dis 48(10):1345–1349
Morgan DJ, Okeke IN, Laxminarayan R, Perencevich EN, Weisenberg S (2011) Non-prescription antimicrobial use worldwide: a systematic review. Lancet Infect Dis 11:692–701
Ministry of Health Turkish Medicines and Medical Devices Agency. Rational Drug Use National Action Plan 2014–2017. Available from http://www.akilciilac.gov.tr/wp-content/uploads/2014/11/Rational-Drug-Use-National-Action-Plan.pdf (accessed at December 27, 2016)
Niederman MS (2005) Principles of appropriate antibiotic use. Int J Antimicrob Agents 26(SUPPL. 3):170–175
Gok H, Akıcı A, Dogukan MN, Dogru ST, Dizici M, Yer M, Mirahmetoglu O (2013) Survey on medicine storage and usage habits of households in Turkey. 7. International, Conference on Quality in Health Care, Accreditation and Patient Safety.(QPS-2013), Antalya, Turkey. 10–13 April 2013. P6.1
Acknowledgements
The authors thank Dr. H. Goossens, Dr. A. Versporten, and M.Sc. Pharm. H.B. Pedersen for their assistance in validation of antibiotic consumption and Dr. H. Gursoz and respective staff/consultants of Turkish Medicines and Medical Devices Agency for their assistance in data collection and calculation of antibiotic consumption.
Authors’ contributions
Ahmet Akici (AhA) and AS planned and designed the study. AhA, VA, and AS performed all data analysis. AS, BM, and MA calculated data for antibiotic consumption. AS, AhA, VA, BM, MA, and Ali Alkan (AlA) were involved in the interpretation of the data. AS, AhA, and VA prepared the manuscript. All authors reviewed the manuscript and approved for publication.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
This research did not receive any specific grant.
Conflict of interest
The authors declare that they have no conflict of interest.
Authors’ information
AS, MD is a family physician in 125. Yil Yahyalar Family Health Center, Ankara, Turkey. AhA, MD is a Professor in Medical Pharmacology Department of Marmara University School of Medicine, Istanbul, Turkey and still a member of “Board of Rational Use of Medicines of Turkish Ministry of Health” since its establishment. VA, MD is a doctorate student in Medical Pharmacology Department of Health Sciences Institute of Marmara University. BM, Pharm. works at Monitoring and Assessment Unit of the Department of Rational Use of Medicines in Turkish Medicines and Medical Devices Agency. MS, Pharm. is the Head of Department of Rational Use of Medicines in Turkish Medicines and Medical Devices Agency. AlA, MD is the Vice President of the Turkish Medicines and Medical Devices Agency in charge of Drug and Pharmacy.
Electronic supplementary material
Online Resource 1
(PDF 79 kb)
Online Resource 2
(PDF 270 kb)
Rights and permissions
About this article
Cite this article
Sahin, A., Akici, A., Aydin, V. et al. Variation of antibiotic consumption and its correlated factors in Turkey. Eur J Clin Pharmacol 73, 867–873 (2017). https://doi.org/10.1007/s00228-017-2229-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-017-2229-z